← back to search

Hongli Lin

Dalian Medical University · CN
Area of research
Nephrology · Pulmonary and Respiratory Medicine
Research interest
Research focused on Interquartile range and Hemodialysis, with related work in Anemia, Dialysis, Confidence interval. Notable publications include 'Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis', 'Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations', and 'Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China'.
h-index
citations
1,304
works
16
NIH funding
primary concept
email

Recent publications

A prospective, randomized, multicenter, open‐label trial comparing survival in subjects receiving peritoneal dialysis or conventional in‐center hemodialysis
Medicine Advances 2024cited by 5position: middledoi
Effectiveness, safety, and treatment pattern of sodium zirconium cyclosilicate in Chinese patients with hyperkalemia: interim analysis from a multicenter, prospective, real-world study (Actualize Study)
Frontiers in Pharmacology 2024cited by 2position: lastdoi
Corrigendum: Effectiveness, safety, and treatment pattern of sodium zirconium cyclosilicate in Chinese patients with hyperkalemia: interim analysis from a multicenter, prospective, real-world study (Actualize Study)
Frontiers in Pharmacology 2024cited by 0position: lastdoi
Iron metabolism and ferroptosis in diabetic bone loss: from mechanism to therapy
Frontiers in Nutrition 2023cited by 27position: middledoi
Efficacy and Safety of Ferric Citrate on Hyperphosphatemia among Chinese Patients with Chronic Kidney Disease Undergoing Hemodialysis: A Phase III Multicenter Randomized Open-Label Active-Drug-Controlled Study
American Journal of Nephrology 2023cited by 4position: middledoi
Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis
New England Journal of Medicine 2019cited by 561position: middledoi
Varying Association of Extended Hours Dialysis with Quality of Life
Clinical Journal of the American Society of Nephrology 2019cited by 20position: middledoi
Assessment of dialysis initiation by a fuzzy mathematics equation (ADIFE): a study protocol for a randomised controlled trial
BMJ Open 2019cited by 2position: lastdoi
Effects of Niaoduqing Particles (尿毒清颗粒) on Delaying Progression of Renal Dysfunction: A Post-trial, Open-Label, Follow-up Study
Chinese Journal of Integrative Medicine 2018cited by 12position: middledoi
Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China
Nephrology Dialysis Transplantation 2017cited by 196position: middledoi
A Trial of Extending Hemodialysis Hours and Quality of Life
Journal of the American Society of Nephrology 2017cited by 81position: middledoi
Analysis of Factors Associated with Death in Maintenance Hemodialysis Patients
Chinese Medical Journal 2017cited by 32position: middledoi
Efficacy and Safety of Niaoduqing Particles for Delaying Moderate-to-severe Renal Dysfunction
Chinese Medical Journal 2017cited by 29position: middledoi
Risk Factor Analysis for AKI Including Laboratory Indicators: a Nationwide Multicenter Study of Hospitalized Patients
Kidney & Blood Pressure Research 2017cited by 25position: middledoi
Anticoagulation treatments relateddifferent types of vascular access onmaintenance hemodialysis patient:A multicenter epidemiologicalinvestigation
Journal of Translational Internal Medicine 2015cited by 1position: middledoi
Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations
Nature Genetics 2014cited by 208position: middledoi
Efficacy and Safety of Abelmoschus manihot for Primary Glomerular Disease: A Prospective, Multicenter Randomized Controlled Clinical Trial
American Journal of Kidney Diseases 2014cited by 125position: middledoi
Association between family members of dialysis patients and chronic kidney disease: a multicenter study in China
BMC Nephrology 2013cited by 15position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Li Zuo · King University5 papers (2013–2019)Xiangmei Chen · Wenzhou Medical University3 papers (2013–2023)Jinsheng Xu · Hebei Medical University3 papers (2013–2019)Janak de Zoysa · University of Auckland2 papers (2017–2019)Jianghua Chen · Zhejiang University2 papers (2017–2019)Ling Zhang · Army Medical University2 papers (2017–2019)Yani He · Shanghai University2 papers (2017–2023)Delong Zhao · Chinese PLA General Hospital2 papers (2015–2017)Meg Jardine · Smart Material (Germany)2 papers (2017–2019) · 2 papers (2017–2019)Hanyu Zhu · Wenzhou Medical University2 papers (2015–2023)Nicholas A. Gray · University of Queensland2 papers (2017–2019) · 2 papers (2017–2019) · 2 papers (2017–2019)Fengmin Shao · Dalian Medical University2 papers (2017–2023)Christopher T. Chan · St Bartholomew's Hospital2 papers (2017–2019)Alan Cass · Menzies School of Health Research2 papers (2017–2019)Vlado Perkovic · UNSW Sydney2 papers (2017–2019)Xuefeng Sun · Hebei Medical University2 papers (2015–2017) · 2 papers (2017–2019)